Anti-SAE1 Ab, IgG
Use
Anti-SAE1 antibodies, IgG type, are evaluated for their clinical significance in autoimmune responses associated with dermatomyositis. Detection of these antibodies can aid in diagnosing patients with specific autoimmune myopathies, contributing to better patient management and therapy planning. The presence of these antibodies is often correlated with specific clinical characteristics, including skin manifestations and muscle weakness, commonly seen in dermatomyositis.
Special Instructions
Not provided.
Limitations
This test is not FDA approved and should be interpreted within the broader clinical context, taking into account the patient's full clinical profile and other laboratory findings. Only samples meeting the specified volume and stability conditions yield reliable results. Hemolysis, lipemia, or icterus could interfere with the accuracy of the test, leading to possible false-negative or false-positive results. Repeat testing may not be feasible with minimum volume samples due to limited material.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
SAE1
Protein
LOINC Codes
- 101220-2 - SAE1 IgG Ser IA-aCnc
- 101220-2 - SAE1 IgG Ser IA-aCnc
Result Turnaround Time
11-14 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Plastic vial
Collection Instructions
Within 1 hour of collection, centrifuge and aliquot 1 mL of serum into a plastic vial. Send refrigerated.
Causes for Rejection
Gross hemolysis, gross lipemia, gross icterus, bacterial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 60 days |